Barrington Research Issues Positive Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price target boosted by Barrington Research from $105.00 to $120.00 in a report issued on Monday,Benzinga reports. Barrington Research currently has an outperform rating on the stock.

Several other analysts have also commented on HQY. BTIG Research increased their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Bank of America upped their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Finally, JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $108.38.

HealthEquity Trading Up 0.1 %

HQY opened at $101.66 on Monday. HealthEquity has a one year low of $62.10 and a one year high of $105.82. The stock has a market cap of $8.88 billion, a price-to-earnings ratio of 84.62, a P/E/G ratio of 1.59 and a beta of 0.52. The stock’s 50 day moving average price is $90.16 and its 200-day moving average price is $82.85. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. On average, equities analysts forecast that HealthEquity will post 2.27 EPS for the current year.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at $387,093.98. This represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock worth $884,517 over the last three months. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently modified their holdings of the company. Wasatch Advisors LP lifted its holdings in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the last quarter. State Street Corp increased its position in HealthEquity by 0.8% during the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the period. Clearbridge Investments LLC raised its position in HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after acquiring an additional 43,491 shares in the last quarter. Mackenzie Financial Corp increased its holdings in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after acquiring an additional 15,145 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.